| Elizabeth Hicks, PHARMD | |
|
2505 Highway 150, Hoover, AL 35244-3533 | |
| (205) 982-9696 | |
| Not Available |
| Full Name | Elizabeth Hicks |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2505 Highway 150, Hoover, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467858985 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 17677 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Hicks, PHARMD 2505 Highway 150, Hoover, AL 35244-3533 Ph: () - | Elizabeth Hicks, PHARMD 2505 Highway 150, Hoover, AL 35244-3533 Ph: (205) 982-9696 |
News Archive
A collaboration between Portuguese and Italian scientists has discovered new subgroups of stomach cancer patients with different disease's characteristics, an information that is hoped will help improving the clinical management of a disease that still kills a dismaying 3 out of 4 patients.
The Lightstone Group announced today that Siemens Corporation signed a 25,498 square-foot, long-term lease at Lightstone Group's Service Center 24 building in James Business Park in St. Rose, La. The Lightstone Group's South Louisiana portfolio, which is managed by Sealy & Company, Inc., is currently 92 percent leased.
Omeros Corporation today announced dosing of the first patient in a second Phase 2 clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor being developed for the treatment of schizophrenia, Huntington's disease (HD) and other cognitive disorders. The Phase 2 trial will evaluate the tolerability, safety, pharmacokinetics and performance on a battery of tests in patients with symptomatic HD.
A new study may alleviate concerns regarding increased cancer risk for patients undergoing spinal fusion surgery with recombinant human bone morphogenetic protein (rhBMP). The study appears in November 15 issue of Spine, published by Wolters Kluwer.
Babies with a high body mass index (BMI) at age two months are at risk for obesity at age two years, say pediatric researchers. The authors, in an online study published today in Pediatrics, say that BMI better predicts early childhood obesity than weight-for-length, the current standard measurement.
› Verified 2 days ago
Megan Elizabeth Monroe, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1584 Montgomery Hwy, Hoover, AL 35216 Phone: 205-824-7223 | |
Dr. Katherine Hunter, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1584 Montgomery Hwy, Hoover, AL 35216 Phone: 205-824-7223 | |
Dr. Laura Smelcer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5188 Caldwell Mill Rd, Hoover, AL 35244 Phone: 205-980-7511 Fax: 205-980-7510 | |
William L Box, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1915 Hoover Ct, Hoover, AL 35226 Phone: 205-822-1151 Fax: 205-822-1183 | |
Nicole Gafford, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5346 Stadium Trace Pkwy, Hoover, AL 35244 Phone: 205-682-8078 | |
Mayank Modi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2780 John Hawkins Pkwy, Hoover, AL 35244 Phone: 205-733-0055 | |
Amy Yates Mills, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2505 Highway 150, Hoover, AL 35244 Phone: 205-982-9696 Fax: 205-982-7824 |